Gulcin Yener Otar

21PUBLICATIONS
125CO-AUTHORS
Infant and child healthMedical virologyPredictive and prognostic markersAutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Mar 13, 2026
Defining Inactivity of Juvenile Spondyloarthropathies: Delphi Study Among Pediatric Rheumatology Academy (PeRA) From Türkiye.

Serkan Türkuçar, Betül Sözeri, Hafize Emine Sönmez

|Dec 14, 2025
Comment on: How early is early for JIA? Insights from the infantile-onset juvenile idiopathic arthritis patients of the PERA research group cohort: reply.

Kubra Ozturk, Tuncay Aydin, Gulcan Ozomay Baykal

|Aug 14, 2025
How early is early for JIA? Insights from the infantile-onset juvenile idiopathic arthritis patients of the PERA research group cohort.

Kubra Ozturk, Tuncay Aydin, Gulcan Ozomay Baykal

|Aug 01, 2025
Three-year follow-up of canakinumab dose extension in children with colchicine-resistant familial Mediterranean fever: PeRA-RG Experience.

Gülşah Kavrul Kayaalp, Şengül Çağlayan, Kadir Ulu

|Apr 21, 2025
Predicting homozygous M694V genotype in paediatric FMF: multicentre analysis and scoring system proposal.

Eray Tunce, Sıla Atamyıldız Uçar, Merve Cansu Polat

|Nov 24, 2024
The journey of MEFV heterozygous children: with or without colchicine.

Mustafa Çakan, Ayşenur Alkaya, Lütfiye Koru

Pageof 4

Frequent Collaborators

16 joint publications

Mustafa Cakan

16 joint publications

Kübra Oztürk

16 joint publications

Nuray Aktay-Ayaz

15 joint publications

Betül Sozeri